Literature DB >> 1545542

Surgical management of isolated multiple ventricular septal defects. Logical approach in 130 cases.

A Serraf1, F Lacour-Gayet, J Bruniaux, R Ouaknine, J Losay, J Petit, J P Binet, C Planché.   

Abstract

From January 1980 through September 1990, 130 children underwent surgical closure of isolated multiple ventricular septal defects (mean age 14 +/- 18 months, mean weight 7.0 +/- 4.4 kg). Sixty-one were less than 1 year of age. Sixty-one children had pulmonary protection, 51 had pulmonary artery banding, and 10 had pulmonary valve stenosis. All other patients had severe pulmonary hypertension (mean systolic pressure 75.7 +/- 20.5 mm Hg and already disabling heart failure (New York Heart Association classes III and IV). The surgical management was based on the location of the defects and the ventricular dominance that were assessed preoperatively and intraoperatively. Midtrabecular ventricular septal defects were always centered by the moderator band and were therefore divided into low trabecular, midtrabecular, and high trabecular defects. The perimembranous septum was involved in 102 patients, the trabecular in 121, the inlet septum in 12, and the infundibular septum in 9. Fifty patients had the "Swiss cheese" form of the lesion. Closure of the ventricular septal defects included Dacron patch and mattress sutures. They were always first approached through a right atriotomy, which was sufficient for complete repair in 82 patients. In midtrabecular ventricular septal defects, section of the moderator band (n = 24) allowed closure of all the defects with a single Dacron patch. In 48 patients a right atriotomy and a right (n = 32) or left (n = 14) (particularly for low trabecular ventricular septal defects) or both right and left (n = 2) ventriculotomies were necessary to secure the repair. The hospital mortality rate was 7.7% (10 patients). The causes of deaths were residual ventricular septal defect (n = 5), pulmonary hypertension (n = 2), hypoplastic right ventricle (n = 1) and left ventricle (n = 1), and myocardial infarction (n = 1). Among eighteen survivors with residual ventricular septal defect, six were reoperated on; there were two deaths. A permanent pacemaker was necessary in four patients. Low trabecular ventricular septal defects and left ventriculotomy were significant risk factors for morbidity (death, residual ventricular septal defect), p less than 0.01. At 7 years of follow-up, 90% of survivors were in New York Heart Association class I. Actuarial survival and freedom from reoperation at 7 years were 89.6% and 87.5%, respectively.

Entities:  

Mesh:

Year:  1992        PMID: 1545542

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  18 in total

Review 1.  Surgical management of muscular trabecular ventricular septal defects.

Authors:  Toshihide Asou
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-11-15

Review 2.  Catheter closure of congenital muscular ventricular septal defects.

Authors:  B D Thanopoulos
Journal:  Pediatr Cardiol       Date:  2005 May-Jun       Impact factor: 1.655

3.  Hybrid pediatric cardiac surgery.

Authors:  E A Bacha; Z M Hijazi; Q-L Cao; R Abdulla; J P Starr; J Quinones; P Koenig; B Agarwala
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

Review 4.  Current topics in surgery for multiple ventricular septal defects.

Authors:  Naoki Yoshimura; Kazuaki Fukahara; Akio Yamashita; Yoshinori Doki; Katsunori Takeuchi; Tomonori Higuma; Kazutaka Senda; Masayoshi Toge; Tatsuro Matsuo; Saori Nagura; Masaya Aoki; Kimimasa Sakata; Mari Sakai
Journal:  Surg Today       Date:  2015-05-03       Impact factor: 2.549

5.  Outcome of transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder.

Authors:  B D Thanopoulos; M L Rigby
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

6.  Multicenter experience with perventricular device closure of muscular ventricular septal defects.

Authors:  E A Bacha; Q L Cao; M E Galantowicz; J P Cheatham; C E Fleishman; S W Weinstein; P A Becker; S L Hill; P Koenig; E Alboliras; R Abdulla; J P Starr; Z M Hijazi
Journal:  Pediatr Cardiol       Date:  2005 Mar-Apr       Impact factor: 1.655

7.  Perventricular device closure of residual muscular ventricular septal defects after repair of complex congenital heart defects in pediatric patients.

Authors:  Da Zhu; Kaiyu Tao; Qi An; Shuhua Luo; Changping Gan; Ke Lin
Journal:  Tex Heart Inst J       Date:  2013

8.  Intraoperative apical ventricular septal defect closure using a modified Rashkind double umbrella.

Authors:  R R Chaturvedi; D F Shore; M Yacoub; A N Redington
Journal:  Heart       Date:  1996-10       Impact factor: 5.994

9.  Perventricular device closure of isolated muscular ventricular septal defect in infants: a single centre experience.

Authors:  Bhavesh Thakkar; Nehal Patel; Shaunak Shah; Vishal Poptani; Tarun Madan; Chirag Shah; Anand Shukla; Vaishali Prajapati
Journal:  Indian Heart J       Date:  2012-09-12

10.  Perventricular closure of muscular ventricular septal defects: How do I do it?

Authors:  Karim A Diab; Qi-Ling Cao; Ziyad M Hijazi
Journal:  Ann Pediatr Cardiol       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.